Medical Countermeasures Strategy

US House Introduces SUPER BUGS Act To Develop Global Antimicrobial Resistance Strategy

The US House has introduced the SUPER BUGS Act of 2026, proposing a global strategy to accelerate the development and commercialization of medical countermeasures against antimicrobial-resistant pathogens. This signals a shift toward coordinated international funding and streamlined regulatory pathways, creating new market access and partnership opportunities for the pharmaceutical and biotech sectors.

5 Apr 2026, 06:11govinfo.govUnited States

EU HaDEA Announces Prior Information Notice on Long-Term API Stockpiling and Rapid Finished Dose Manufacture

The EU is launching a €6 million pilot project in May 2026 to develop technologies for long-term API stockpiling and rapid pharmaceutical manufacturing. This initiative signals a strategic shift toward advanced shelf-life extension and localized production capabilities to bolster regional supply chain resilience.

4 Apr 2026, 10:30op.europa.euEuropean Union

Netherlands VWS Minister Confirms Structural Funding and Embedding of Pandemic Preparedness Programme

The Dutch government has committed €177 million annually to structurally embed pandemic preparedness into national health policy, focusing on surveillance, acute-care coordination, and medical countermeasure resilience. For life sciences and medical device sectors, this signals long-term investment in strategic stockpiling, supply chain resilience, and scalable production capacity for vaccines and diagnostics.

2 Apr 2026, 10:18zoek.officielebekendmakingen.nlNetherlands

Japan METI and MHLW Establish Taskforce to Secure Pharmaceuticals, Medical Devices and Medical Supplies Affected by Middle East Situation

Japan has established a joint ministerial taskforce to address supply chain vulnerabilities for pharmaceuticals and medical devices linked to geopolitical instability in the Middle East. Businesses should anticipate increased government scrutiny of supply resilience and potential future measures to ensure the stable availability of critical medical supplies.

1 Apr 2026, 19:46meti.go.jpJapan

UK Adopts Human Medicines (Amendment) Regulations 2026 on Vaccination and Pharmacist Compounding

The UK has adopted the Human Medicines (Amendment) Regulations 2026, effective 31 March 2026, to streamline vaccine administration and pharmacist compounding. Businesses should assess updated licensing exemptions for vaccine distribution and ensure compliance with new packaging and labeling standards for bespoke medicines.

29 Mar 2026, 17:26legislation.gov.ukUnited Kingdom

Norway Proposes Amendments to Pharmacy, Medicines and Medical Devices Laws to Implement EU Crisis Preparedness Regulations

Norway has proposed legislation to implement EU crisis preparedness and medical device supply regulations, mandating new reporting duties for market actors. Manufacturers and distributors must prepare for increased supply-chain transparency and the formal adoption of EUDAMED notification requirements in the Norwegian market.

29 Mar 2026, 05:58regjeringen.noNorwayEuropean Economic Area

European Parliament SEDE Amendments on Union Civil Protection Mechanism and Health Emergency Preparedness

The European Parliament is advancing amendments to the Union Civil Protection Mechanism to strengthen CBRN threat response and centralized stockpiling of medical countermeasures. Manufacturers of dual-use equipment and medical supplies should anticipate increased EU-level procurement coordination and potential capacity pre-registration requirements.

28 Mar 2026, 09:33europarl.europa.euEuropean Union

Brazil (Anvisa) Dicol Agenda Includes Normative Instruction To Update COVID-19 Vaccine Composition

Brazil’s Anvisa is set to deliberate on a new Normative Instruction to update the mandatory composition of COVID-19 vaccines during its March 2026 board meeting. Manufacturers must prepare for formulation adjustments and regulatory re-submissions to maintain market access as Brazil aligns its vaccine requirements with current epidemiological data.

27 Mar 2026, 18:16gov.brBrazil

EU / France Commission Delivers Comments on Draft Decree on Medicinal Product Shortages (Notification 2025/0795/FR)

The European Commission has formally commented on France's draft decree to combat medicinal product shortages under the TRIS notification procedure. This intervention signals potential regulatory misalignment with EU single market rules, requiring pharmaceutical operators to monitor for changes in stockholding or supply obligations in the final French text.

27 Mar 2026, 11:57ec.europa.euEuropean UnionFrance

UK Health Security Agency Updates Spikevax Refrigerated Storage Temperature to +2°C to +8°C

The UK Health Security Agency has updated the mandatory refrigerated storage temperature range for the Spikevax vaccine to +2°C to +8°C. Organizations must immediately align cold-chain logistics and clinical handling procedures with these revised specifications to ensure product efficacy and regulatory compliance.

27 Mar 2026, 08:28gov.ukUnited Kingdom

EU Council Working Party on Civil Protection To Discuss UCPM-HER Proposal and Stockpiling of Medical Countermeasures

EU Council negotiations are progressing on the UCPM-HER proposal, specifically addressing the Crisis Support Hub and long-term medical countermeasure stockpiling. This signals a shift toward a more centralized EU health emergency response, impacting future procurement cycles and supply chain requirements for medical and pharmaceutical sectors.

26 Mar 2026, 19:14data.consilium.europa.euEuropean Union

Estonia Appoints First Essential-Service Pharmacies and Wholesalers for Medicine Supply

Estonia has designated the first pharmacies and wholesalers as essential service providers (ETO), mandating strict crisis-response and supply continuity obligations starting February 2026. Impacted entities must align operations with new 48-hour restoration and 5-day autonomy standards, reflecting a broader regional trend toward mandatory pharmaceutical supply chain resilience.

26 Mar 2026, 11:44ravimiamet.eeEstonia

Minnesota Department of Health Extends Use of RSV Monoclonal Antibodies Through 30 April 2026

Minnesota has extended the administration period for RSV monoclonal antibodies through April 30, 2026, citing sustained viral activity and hospitalization risks. Healthcare and pharmaceutical organizations should adjust supply chain logistics and patient outreach to ensure continued access and reimbursement during the extended season.

19 Mar 2026, 10:06health.state.mn.usUnited States

European Commission Opens Call For Evidence On EU Global Health Resilience Initiative

The European Commission has opened a call for evidence (until April 13, 2026) to shape its Global Health Resilience Initiative focused on international health security and local manufacturing. This initiative signals a strategic shift toward decentralized production and reinforced health governance, impacting long-term supply chain planning and market access for the life sciences sector.

18 Mar 2026, 15:57ec.europa.euEuropean Union

Taiwan TFDA Announces 2026 Medical Device Supply Fragility Risk Assessment and Reserve System Tender (Case 115TFDA-MD-028)

Taiwan's TFDA has initiated a project to assess medical device supply chain fragility and establish a national reserve system for 2026. This signals a move toward stricter supply chain monitoring and potential future obligations for manufacturers to support national resilience efforts.

16 Mar 2026, 16:38fda.gov.twTaiwan

EU Parliament Draft Report on Union Civil Protection Mechanism and Health Emergency Preparedness Regulation (2025/0223)

The European Parliament published a draft report in March 2026 to strengthen the Union Civil Protection Mechanism and health emergency preparedness framework. Companies in critical sectors should anticipate more frequent risk reporting and potential strategic stockpiling mandates for essential medical and emergency supplies.

13 Mar 2026, 06:33europarl.europa.euEuropean Union

EU Council Prepares Trilogues on Critical Medicines Act Proposal

The EU has entered final negotiations on the Critical Medicines Act, moving toward a finalized framework for pharmaceutical supply security. Manufacturers should prepare for new non-price procurement criteria and potential obligations for strategic stockpiling and EU-based production capacity.

11 Mar 2026, 17:27eur-lex.europa.euEuropean Union

EU Council Four-Column Table on Critical Medicines Supply Framework Proposal

The EU Council has initiated trilogue negotiations on the Critical Medicines Act, signaling that final rules for securing the supply of essential pharmaceuticals are nearing completion. Pharmaceutical companies should prepare for new obligations regarding the availability and accessibility of critical medicines as the legislative framework moves toward formal adoption.

11 Mar 2026, 17:26consilium.europa.euEuropean Union

EU Commission Publishes Recommendations on Preparedness and Response to Serious Cross-Border Health Threats Under Regulation (EU) 2022/2371

The EU Commission has issued high-level recommendations for national preparedness against cross-border health threats, focusing on medical countermeasures, surveillance, and supply chain resilience. These priorities will likely drive national requirements for healthcare providers and manufacturers regarding stockpiling, emergency research, and surge capacity.

10 Mar 2026, 12:55health.ec.europa.euEuropean UnionEuropean Economic Area

US House Introduces PASTEUR Act of 2026 on Novel Antimicrobial Subscription Contracts

The US House introduced the PASTEUR Act of 2026, proposing a $6 billion subscription-based model to incentivize the development and availability of novel antimicrobials. This shift toward value-based federal contracting would require manufacturers to meet strict environmental discharge standards and stewardship obligations to secure guaranteed revenue streams.

10 Mar 2026, 12:42govinfo.govUnited States